European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection
- PMID: 12639222
- DOI: 10.1079/PHN2002394
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection
Abstract
The European Prospective Investigation into Cancer and Nutrition (EPIC) is an ongoing multi-centre prospective cohort study designed to investigate the relationship between nutrition and cancer, with the potential for studying other diseases as well. The study currently includes 519 978 participants (366 521 women and 153 457 men, mostly aged 35-70 years) in 23 centres located in 10 European countries, to be followed for cancer incidence and cause-specific mortality for several decades. At enrollment, which took place between 1992 and 2000 at each of the different centres, information was collected through a non-dietary questionnaire on lifestyle variables and through a dietary questionnaire addressing usual diet. Anthropometric measurements were performed and blood samples taken, from which plasma, serum, red cells and buffy coat fractions were separated and aliquoted for long-term storage, mostly in liquid nitrogen. To calibrate dietary measurements, a standardised, computer-assisted 24-hour dietary recall was implemented at each centre on stratified random samples of the participants, for a total of 36 900 subjects. EPIC represents the largest single resource available today world-wide for prospective investigations on the aetiology of cancers (and other diseases) that can integrate questionnaire data on lifestyle and diet, biomarkers of diet and of endogenous metabolism (e.g. hormones and growth factors) and genetic polymorphisms. First results of case-control studies nested within the cohort are expected early in 2003. The present paper provides a description of the EPIC study, with the aim of simplifying reference to it in future papers reporting substantive or methodological studies carried out in the EPIC cohort.
Similar articles
-
The European Prospective Investigation into Cancer and Nutrition biobank.Methods Mol Biol. 2011;675:179-91. doi: 10.1007/978-1-59745-423-0_7. Methods Mol Biol. 2011. PMID: 20949388
-
European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics.Public Health Nutr. 2002 Dec;5(6B):1125-45. doi: 10.1079/PHN2002395. Public Health Nutr. 2002. PMID: 12639223
-
The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition.Int J Epidemiol. 1997;26 Suppl 1:S6-14. doi: 10.1093/ije/26.suppl_1.s6. Int J Epidemiol. 1997. PMID: 9126529
-
The European Prospective Investigation into Cancer and Nutrition (EPIC).Public Health Nutr. 2006 Feb;9(1A):124-6. doi: 10.1079/phn2005934. Public Health Nutr. 2006. PMID: 16512959 Review.
-
Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results. European Prospective Investigation into Cancer and Nutrition.Int J Epidemiol. 1997;26 Suppl 1:S26-36. doi: 10.1093/ije/26.suppl_1.s26. Int J Epidemiol. 1997. PMID: 9126531 Review.
Cited by
-
Adherence to a Mediterranean diet associated with lower blood pressure in a US sample: Findings from the Maine-Syracuse Longitudinal Study.J Clin Hypertens (Greenwich). 2020 Dec;22(12):2276-2284. doi: 10.1111/jch.14068. Epub 2020 Oct 12. J Clin Hypertens (Greenwich). 2020. PMID: 33045144 Free PMC article.
-
Risk of type 2 diabetes according to traditional and emerging anthropometric indices in Spain, a Mediterranean country with high prevalence of obesity: results from a large-scale prospective cohort study.BMC Endocr Disord. 2013 Feb 6;13:7. doi: 10.1186/1472-6823-13-7. BMC Endocr Disord. 2013. PMID: 23388074 Free PMC article.
-
Valuing the Diversity of Research Methods to Advance Nutrition Science.Adv Nutr. 2022 Aug 1;13(4):1324-1393. doi: 10.1093/advances/nmac043. Adv Nutr. 2022. PMID: 35802522 Free PMC article.
-
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models.J Hematol Oncol. 2013 Sep 6;6:67. doi: 10.1186/1756-8722-6-67. J Hematol Oncol. 2013. PMID: 24010981 Free PMC article. Clinical Trial.
-
Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study.BMJ Open. 2020 Mar 8;10(3):e033532. doi: 10.1136/bmjopen-2019-033532. BMJ Open. 2020. PMID: 32152162 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases